Table 1.
Bordetella bronchiseptica-specific antibody responses before and after vaccination of client-owned dogs
| Dog | Breed, Age (years) | Last Bb Vx | ELISAe at Vx | Vaccine | ELISA at D10 | Δ inhibitionf |
|---|---|---|---|---|---|---|
| 1aSa | Sheltie, 5 | NAb | 13 | INJ | 17 | 0% |
| 1bS | Sheltie, 3 | NA | 15 | INJ | 34 | 0% |
| 1cS | Labrador retriever, 6 | NA | 16 | None | 10 | 38% |
| 2aS | Golden retriever, 4 | INc 6 mo ago | 75 | INJ | 70 | 22% |
| 2bS | Catahoula cross, 1 | IN 8 mo ago | 84 | INJ | 117 | 36% |
| 2cS | Pit bull cross, 3 | NA | 49 | None | 44 | 0% |
| 3aS | Bernese mountain dog, 6 | INJd 9 mo ago | 20 | INJ | 87 | 30% |
| 3bS | Great Dane, 4 | NA | 100 | INJ | 114 | 3% |
| 3cS | Golden retriever, 6 | IN 9 mo ago | 80 | None | 79 | 23% |
| 4aF | Labrador retriever, 4 | NA | 3 | INJ | 14 | 23% |
| 4bF | Labrador retriever, 10 | NA | 0 | INJ | 11 | 0% |
| 4cF | Labrador retriever, 12 | NA | 7 | None | 5 | 0% |
| 5aF | Terrier cross, 1 | INJ 9 mo ago | 46 | INJ | 94 | 0% |
| 5bF | Staffordshire cross, 4 | INJ 5 mo ago | 30 | None | 34 | 0% |
a
Household number (1 to 5); dog in household (a–c); environment (S = suburban; F = rural).
b
NA — no vaccination history available.
c
IN — intranasal B. bronchiseptica vaccine.
d
INJ — injectable B. bronchiseptica vaccine.
e
ELISA at Vx — units of IgG in B. bronchiseptica ELISA.
f
Δ inhibition — % increased inhibition of bacterial growth (% change in opitical density value from baseline).